Explore more about: Cancer

An NIH-funded team at the University of Colorado (UC) has assembled a clearer picture of the molecular activity that occurs when nanoparticles injected into the body are marked for immune system attack.

A computer program using radiomic features found in routine MRI scans to distinguish between radiation necrosis and recurrent brain cancer has been developed.

Researchers have developed nanorobotic agents that can navigate through the bloodstream to administer a drug by targeting the active cancerous cells of tumors.

A new phase 1 clinical trial evaluated the differences between pre-operative prone and supine MRI exams in 12 women undergoing lumpectomy for breast cancer.

Study describes the use of restriction spectrum imaging as a biomarker that enhances the ability of MRI to differentiate aggressive cancer from benign tumors.

Research findings contradict belief that CTC clusters are too large to pass through capillaries and suggest strategies to reduce clusters' metastatic potential.

Scientists have discovered a new class of molecular tags that enhance MRI signals by 10,000-fold and generate detectable signals that last over an hour.

A method using acoustic waves in a microfluidic device to rotate single particles, cells or organisms will allow researchers to take 3-D images with a phone.

A new way to analyze breast cancer MRI data appears to reliably distinguish between patients who would need hormonal treatment versus needing chemotherapy.

Researchers revealed that radiotracer PET/CT scans that targets prostate-specific membrane antigen was best at detecting metastatic prostate cancer.